loading
Precedente Chiudi:
$57.07
Aprire:
$57.53
Volume 24 ore:
123.49K
Relative Volume:
0.11
Capitalizzazione di mercato:
$9.60B
Reddito:
$29.52M
Utile/perdita netta:
$-519.21M
Rapporto P/E:
-17.62
EPS:
-3.26
Flusso di cassa netto:
$-520.21M
1 W Prestazione:
+0.08%
1M Prestazione:
+20.24%
6M Prestazione:
+44.77%
1 anno Prestazione:
+176.17%
Intervallo 1D:
Value
$56.50
$58.28
Intervallo di 1 settimana:
Value
$53.69
$58.28
Portata 52W:
Value
$20.86
$62.40

Revolution Medicines Inc Stock (RVMD) Company Profile

Name
Nome
Revolution Medicines Inc
Name
Telefono
415-766-3638
Name
Indirizzo
700 SAGINAW DR, REDWOOD CITY, CA
Name
Dipendente
490
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-06
Name
Ultimi documenti SEC
Name
RVMD's Discussions on Twitter

Confronta RVMD con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
RVMD 57.43 9.60B 29.52M -519.21M -520.21M -3.26
VRTX 447.41 115.74B 10.63B -479.80M -1.35B 13.33
REGN 742.11 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 589.03 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 250.03 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.69 24.49B 3.30B -501.07M 1.03B 11.54

Revolution Medicines Inc Stock (RVMD) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-07-16 Reiterato Needham Buy
2024-07-12 Iniziato Barclays Overweight
2024-07-08 Iniziato Jefferies Buy
2024-04-12 Reiterato Needham Buy
2024-04-10 Aggiornamento Raymond James Outperform → Strong Buy
2024-03-11 Iniziato Piper Sandler Overweight
2024-01-05 Aggiornamento BofA Securities Neutral → Buy
2024-01-04 Iniziato Wedbush Outperform
2023-11-16 Iniziato Raymond James Outperform
2023-02-28 Aggiornamento JP Morgan Neutral → Overweight
2022-12-14 Iniziato Needham Buy
2022-10-21 Iniziato Oppenheimer Outperform
2022-05-20 Iniziato BofA Securities Neutral
2022-03-01 Aggiornamento Stifel Hold → Buy
2021-09-23 Iniziato Stifel Hold
2021-08-12 Downgrade Goldman Buy → Neutral
2021-05-18 Iniziato Goldman Buy
2020-05-21 Iniziato H.C. Wainwright Buy
2020-03-09 Iniziato Cowen Outperform
2020-03-09 Iniziato Guggenheim Buy
2020-03-09 Iniziato JP Morgan Neutral
Mostra tutto

Revolution Medicines Inc Borsa (RVMD) Ultime notizie

pulisher
Nov 19, 2024

Victory Capital Management Inc. Sells 104,851 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Nov 19, 2024
pulisher
Nov 16, 2024

Revolution Medicines, Inc. (NASDAQ:RVMD) Receives $61.00 Average Price Target from Brokerages - Defense World

Nov 16, 2024
pulisher
Nov 15, 2024

Revolution Medicines executive sells shares worth $977,508 By Investing.com - Investing.com Australia

Nov 15, 2024
pulisher
Nov 15, 2024

Revolution Medicines executive sells shares worth $977,508 - Investing.com

Nov 15, 2024
pulisher
Nov 15, 2024

Revolution Medicines' SWOT analysis: stock rises on cancer drug pipeline By Investing.com - Investing.com Australia

Nov 15, 2024
pulisher
Nov 15, 2024

Revolution Medicines' SWOT analysis: stock rises on cancer drug pipeline - Investing.com India

Nov 15, 2024
pulisher
Nov 13, 2024

Revolution Medicines, Inc. (NASDAQ:RVMD) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Nov 13, 2024
pulisher
Nov 11, 2024

Revolution Medicines (NASDAQ:RVMD) Reaches New 12-Month HighStill a Buy? - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

HC Wainwright Issues Pessimistic Estimate for RVMD Earnings - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

What is Wedbush's Forecast for RVMD FY2024 Earnings? - MarketBeat

Nov 11, 2024
pulisher
Nov 09, 2024

Revolution Medicines' general counsel sells $360,000 in stock - Investing.com India

Nov 09, 2024
pulisher
Nov 09, 2024

Revolution Medicines Stock Soars to All-Time High of $60.53 By Investing.com - Investing.com Canada

Nov 09, 2024
pulisher
Nov 09, 2024

Decoding Revolution Medicines Inc (RVMD): A Strategic SWOT Insight - Yahoo Finance

Nov 09, 2024
pulisher
Nov 09, 2024

Decoding Revolution Medicines Inc (RVMD): A Strategic SWOT Insig - GuruFocus.com

Nov 09, 2024
pulisher
Nov 08, 2024

Wellington Management Group LLP Reduces Stake in Revolution Medi - GuruFocus.com

Nov 08, 2024
pulisher
Nov 08, 2024

Revolution Medicines' general counsel sells $360,000 in stock By Investing.com - Investing.com UK

Nov 08, 2024
pulisher
Nov 08, 2024

Revolution Medicines Stock Soars to All-Time High of $60.53 - Investing.com

Nov 08, 2024
pulisher
Nov 08, 2024

Earnings call: Revolution Medicines reports on RAS(ON) inhibitors progress By Investing.com - Investing.com Australia

Nov 08, 2024
pulisher
Nov 07, 2024

Earnings call: Revolution Medicines reports on RAS(ON) inhibitors progress - Investing.com

Nov 07, 2024
pulisher
Nov 07, 2024

HC Wainwright Issues Negative Outlook for RVMD Earnings - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

JPMorgan Chase & Co. Issues Positive Forecast for Revolution Medicines (NASDAQ:RVMD) Stock Price - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Revolution Medicines Inc (RVMD) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Rising Expenses - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Revolution Medicines Inc (RVMD) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

Nov 07, 2024
pulisher
Nov 07, 2024

Revolution Medicines Inc (RVMD) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... By GuruFocus - Investing.com Canada

Nov 07, 2024
pulisher
Nov 07, 2024

Revolution Medicines Reports Q3 2024 Results and Progress - TipRanks

Nov 07, 2024
pulisher
Nov 06, 2024

Revolution Medicines Reports Third Quarter 2024 Financial Results and Update on Corporate Progress - The Manila Times

Nov 06, 2024
pulisher
Nov 06, 2024

Revolution Medicines' SWOT analysis: cancer drug developer's stock potential By Investing.com - Investing.com Australia

Nov 06, 2024
pulisher
Nov 05, 2024

Revolution Medicines CEO Mark A. Goldsmith sells $3.88 million in stock - Investing.com Canada

Nov 05, 2024
pulisher
Nov 05, 2024

Revolution Medicines (NASDAQ:RVMD) Sets New 1-Year HighWhat's Next? - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Revolution Medicines Inc (RVMD) Q3 2024 Earnings Report Preview: What To Look For - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

Revolution Medicines to Participate in Upcoming Investor Conferences - The Manila Times

Nov 05, 2024
pulisher
Nov 05, 2024

Revolution Medicines' SWOT analysis: cancer drug developer's stock potential - Investing.com India

Nov 05, 2024
pulisher
Nov 05, 2024

Brokerage firm bumps Revolution Medicines stock PT on positive trial data - Investing.com Canada

Nov 05, 2024
pulisher
Nov 04, 2024

(RVMD) Long Term Investment Analysis - Stock Traders Daily

Nov 04, 2024
pulisher
Nov 01, 2024

Revolution Medicines (NASDAQ:RVMD) Given New $60.00 Price Target at Oppenheimer - Defense World

Nov 01, 2024
pulisher
Oct 31, 2024

Revolution Medicines (RVMD) Set to Announce Earnings on Wednesday - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Allspring Global Investments Holdings LLC Raises Stock Position in Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Oct 31, 2024
pulisher
Oct 30, 2024

Revolution Medicines stock hits 52-week high at $51.01 By Investing.com - Investing.com South Africa

Oct 30, 2024
pulisher
Oct 30, 2024

Revolution Medicines to Report Financial Results for Third Quarter 2024 After Market Close on November 6, 2024 - The Manila Times

Oct 30, 2024
pulisher
Oct 30, 2024

Revolution Medicines stock hits 52-week high at $51.01 - Investing.com

Oct 30, 2024
pulisher
Oct 30, 2024

Raymond James & Associates Purchases 116,135 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Oct 30, 2024
pulisher
Oct 29, 2024

China Universal Asset Management Co. Ltd. Purchases 12,744 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Oct 29, 2024
pulisher
Oct 28, 2024

Revolution Medicines (NASDAQ:RVMD) PT Raised to $82.00 - MarketBeat

Oct 28, 2024
pulisher
Oct 28, 2024

Revolution Medicines Targets Hard-to-Treat Pancreatic Cancer With Two Early-Phase Readouts - BioSpace

Oct 28, 2024
pulisher
Oct 26, 2024

Revolution Medicines reports positive RMC-9805 study results - Investing.com India

Oct 26, 2024
pulisher
Oct 25, 2024

Revolution Medicines reports positive RMC-9805 study results By Investing.com - Investing.com Australia

Oct 25, 2024

Revolution Medicines Inc Azioni (RVMD) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):